Literature DB >> 6421520

Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.

S Uwatoko, S Aotsuka, M Okawa, Y Egusa, R Yokohari, C Aizawa, K Suzuki.   

Abstract

The molecular size of C1q-binding immunoglobulin (Ig) G complexes in systemic lupus erythematosus (SLE) sera was studied by gel filtration using C1q solid-phase radioimmunoassay (C1q SPRIA). All 15 SLE sera tested contained predominantly small-sized IgG complexes, cofractionating with monomeric IgG. In contrast to heat-aggregated IgG, these small-sized IgG complexes retained C1q-binding activity even after pepsin digestion, exposure to low pH, or reduction and alkylation, suggesting that the F(ab')2 region is involved in C1q-binding activity of these complexes. To see whether anti-C1q antibodies or small antigen-IgG complexes, which bind to C1q via their antigens, are responsible for C1q-binding activity via the F(ab')2 region, the pepsin-digested Ig fractions of SLE sera were fractionated at high salt. C1q-binding activity in the fractions corresponding to the F(ab')2 region increased 2.5- to 3.9-fold at high salt. These results suggest that the C1q-binding, small-sized IgG complexes may be comprised mostly of anti-C1q antibodies and that some of the antibodies, which are dissociated with their antigens at high salt, might be cross-reactive with C1q.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421520     DOI: 10.1016/0090-1229(84)90011-4

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  26 in total

Review 1.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  Antibodies against C1q in anti-glomerular basement membrane nephritis.

Authors:  I E Coremans; M R Daha; E A van der Voort; Y Muizert; C Halma; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 4.  Urticarial vasculitis and syndromes in association with connective tissue diseases.

Authors:  R A Asherson; R Sontheimer
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

Review 6.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 7.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

Review 8.  Mechanisms of immune deposit formation in renal glomeruli.

Authors:  M H Wener; M Mannik
Journal:  Springer Semin Immunopathol       Date:  1986

9.  Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.

Authors:  S Uwatoko; M Mannik
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

10.  Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; C M Tseng; I E Coremans; L A van Es; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.